StockData
WATNYSELaboratory Analytical InstrumentsFiscal year ends December 31

WATERS CORP /DE/

Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 11, 2026
$434.27−2.68 (-0.61%)

Close on Oct 19, 2026

Market cap
$42.65T
P/E (TTM)
108.3
Dividend yield
–

About Waters

Laboratory Analytical Instruments, SIC 3826

Waters Corporation designs, develops, manufactures, distributes, and services analytical instruments, software platforms, and laboratory consumables. Its core technologies encompass liquid chromatography, mass spectrometry, thermal analysis, rheometry, and calorimetry systems, alongside chromatography columns, specialized sample preparation products, and comprehensive post-warranty maintenance services. With the addition of diagnostic and bioscience solutions, the company organizes its operations across four principal segments: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences. Its solutions primarily serve customers in the pharmaceutical and life sciences industries, while also supporting industrial manufacturers, environmental testing laboratories, nutritional safety facilities, clinical diagnostic centers, academic institutions, and government agencies.

The enterprise conducts operations on an international scale, distributing products and providing technical support through 82 sales offices situated around the world. Its global commercial outreach is supported by approximately 4,300 field representatives who directly handle customer accounts, instrument installations, training, and maintenance. Waters maintains manufacturing, testing, and machining capabilities at its facility in Milford, Massachusetts.

Summary of the business section of Waters's latest annual report, written by StockData.

Company profile

Company

Legal name
WATERS CORP /DE/
Founded
1991
Headquarters
Milford, MA
Address
34 Maple St 01757
Phone
(508) 478-2000
Employees
7,600, Dec 31, 2024
Industry
Laboratory Analytical Instruments
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Boston, Massachusetts

Stock & identifiers

Ticker
WAT
Exchange
NYSE
IPO date
Oct 31, 1996
Shares outstanding
98M, Aug 7, 2026
Public float
$20.97B, Jun 28, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Aug 28, 2000; 2-for-1, Jun 11, 1999
SEC CIK
1000697
CUSIP
941848103
ISIN
US9418481035
LEI
5T547R1474YC9HOD8Q74
EIN
13-3668640

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Udit BatraPresident and CEO, Director33,140
Tong (NMN) WuSVP Waters Analytical Sciences–
Robert L. Carpio IIISVP Waters Analytical Sciences3,426
Amol ChaubalSVP & Chief Financial Officer7,835
Jianqing BennettSVP Waters Adv. Diagnostics6,532
Christopher A. KueblerDirector17,808
Heather KnightDirector1,281
Wei JiangDirector3,573
Richard H. FearonDirector3,302
Linda BaddourDirector2,899
Flemming OrnskovDirector5,271
Claire FraserDirector489
Pearl S. HuangDirector3,276
Daniel J. BrennanDirector1,355
Mark VergnanoDirector4,540

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Dr.Batra
$13.97M$10.65M$3.21M$154$69
FY2024
Dr.Batra
$11.15M$14.56M$2.53M$150$72
FY2023
Dr.Batra
$8.74M-$1.12M$2.34M$133$76
FY2022
Dr.Batra
$9.41M$10.83M$2.69M$138$86
FY2021
Dr.Batra
$8.65M$19.06M$2.44M$151$127
FY2020
Dr.Batra
$5.71M$6.98M$1.92M$106$129

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“With approximately 7,600 employees worldwide, Waters operates directly in over 35 countries and has products available in more than 100 countries.”

Corporate history

Events identified from SEC filings